REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sinclair Pharmaceuticals Limited Sp. z o.o. Oddzial W Polsce (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Department Stores | Advertising Agencies | All Other Professional, Scientific, and Technical Services | Packaging and Labeling Services | All Other Support Services
Full name: Sinclair Pharmaceuticals Limited Sp. z o.o. Oddzial W Polsce Profile Updated: November 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Sinclair Pharmaceuticals Limited Sp. z o.o. Oddzial W Polsce is based in Poland. The head office is in Chester. The company operates in the Pharmaceutical Preparation Manufacturing sector. It was established on April 12, 2021. From the latest financial highlights, Sinclair Pharmaceuticals Limited Sp. z o.o. Oddzial W Polsce reported a net sales revenue increase of 47.3% in 2023. Its total assets grew by 45.36% over the same period. The net profit margin of Sinclair Pharmaceuticals Limited Sp. z o.o. Oddzial W Polsce increased by 1.09% in 2023.

Headquarters
Lakeside
Chester; Eden House Chster Business Park; Postal Code: 49

Contact Details: Purchase the Sinclair Pharmaceuticals Limited Sp. z o.o. Oddzial W Polsce report to view the information.

Basic Information
Outstanding Shares:
Purchase the Sinclair Pharmaceuticals Limited Sp. z o.o. Oddzial W Polsce report to view the information.
Incorporation Date:
April 12, 2021
Key Executives
Purchase this report to view the information.
Power of Attorney
Purchase this report to view the information.
Power of Attorney
Company Performance
Financial values in the chart are available after Sinclair Pharmaceuticals Limited Sp. z o.o. Oddzial W Polsce report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
47.3%▲
Total operating revenue
47.41%▲
Operating profit (EBIT)
76%▲
Net Profit (Loss) for the Period
82.56%▲
Total assets
45.36%▲
Total equity
47.1%▲
Operating Profit Margin (ROS)
1.23%▲
Net Profit Margin
1.09%▲
Return on Equity (ROE)
6.33%▲
Quick Ratio
0.23%▲
Cash Ratio
0.1%▲

Similar companies

Adamed Pharma S.A.
 
"Przedsiebiorstwo Produkcji Farmaceutycznej Hasco - Lek" S.A.
Tarchominskie Zaklady Farmaceutyczne "Polfa" S.A.
 
Ziaja Ltd Zaklad Produkcji Lekow Sp. z o.o.
Maco Productions Polonia Sp. z o.o.
 
Orifarm Manufacturing Poland Sp. z o.o.
Vitasynth Sp. z o.o.
 
Advanced Accelerator Applications Polska Sp. z o.o.
"Gryfarm" Sp. z o.o.
 
Instytut Dermokosmetykow Ideepharm Sp. z o.o.
"Nucmed" Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo